Recent News

• 04.10.2025 - BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn® in ALS
• 03.31.2025 - BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update
• 03.26.2025 - BrainStorm Cell Therapeutics Granted Compliance Extension from Nasdaq
• 03.24.2025 - BrainStorm to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Corporate Update

Recent Filings

• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.31.2025 - 8-K Current report
• 03.31.2025 - 8-K Current report
• 03.31.2025 - EX-99.1 EX-99.1
• 03.27.2025 - 8-K Current report
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.21.2025 - 8-K Current report
• 01.15.2025 - 8-K Current report
• 01.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.07.2025 - 3/A Initial statement of beneficial ownership of securities